Jacobson Pharma Corporation Limited (2633.HK)
HKD 1.01
(0.0%)
HKD 1.01
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 484.36 Million | 648.23 Million | 409.75 Million | 411.34 Million | 375.59 Million | 395.7 Million |
| Net Income | 319.02 Million | 251.04 Million | 177.66 Million | 173.71 Million | 214.49 Million | 250.56 Million |
| Depreciation & Amortization | 156.52 Million | 184.46 Million | 192.59 Million | 191.7 Million | 166.27 Million | 111.1 Million |
| Deferred income taxes | - | -301.22 Million | - | - | -386.17 Million | 33.82 Million |
| Stock-based compensation | 19.36 Million | 19.13 Million | - | - | 1.5 Million | 5.34 Million |
| Change in working capital | -13.72 Million | 86.82 Million | -443 Thousand | -212 Thousand | -52.12 Million | -39.17 Million |
| Other non-cash items | 57.47 Million | 407.99 Million | 39.93 Million | 46.14 Million | 431.62 Million | 34.04 Million |
| Investing Cash Flow | 43.34 Million | -44.08 Million | -52.75 Million | -375.4 Million | -451.74 Million | -626.78 Million |
| Investments in PPE | -129.5 Million | -63 Million | -63.86 Million | -63.35 Million | -84.4 Million | -44.07 Million |
| Acquisitions | 9.12 Million | 10.47 Million | -11.34 Million | -199.8 Million | -107.25 Million | -370.46 Million |
| Investment purchases | - | -1.55 Million | -50.57 Million | -144.04 Million | -260.27 Million | -185.24 Million |
| Sales/Maturities of investments | 135.32 Million | 10 Million | 73.54 Million | 51 Million | -1.00 | 12.41 Million |
| Other Investing Activities | 28.4 Million | -72.88 Million | -510 Thousand | -19.21 Million | 187 Thousand | -39.42 Million |
| Financing Cash Flow | -1.05 Billion | -45.64 Million | -357.88 Million | 21.35 Million | -133.06 Million | 206.19 Million |
| Debt repayment | -720 Million | -136.19 Million | -260.67 Million | -3.63 Million | -178.98 Million | -783.42 Million |
| Dividends payments | -93.6 Million | -104.02 Million | -51.72 Million | -63.21 Million | -100.23 Million | -88.68 Million |
| Common Stock Repurchased | -7.68 Million | -32.42 Million | - | -1.5 Million | -150.89 Million | 371.76 Million |
| Common Stock Issuance | 31.21 Million | -32.42 Million | - | 145.25 Million | -23.26 Million | 411.65 Million |
| Other Financing Activities | -152.15 Million | 259.42 Million | -45.48 Million | -55.55 Million | 320.3 Million | 294.88 Million |
| Accounts receivables | -68.27 Million | 23.77 Million | -62.78 Million | -38.82 Million | 2000.00 | -21.66 Million |
| Accounts payables | 63.84 Million | 116.5 Million | 20.71 Million | 17.67 Million | -391 Thousand | 6.75 Million |
| Inventory | -9.3 Million | -53.45 Million | 41.62 Million | 20.93 Million | -51.73 Million | -17.5 Million |
| Other working capital | 63.84 Million | - | - | - | - | -6.75 Million |
| Cash at beginning of period | 936.41 Million | 478.65 Million | 480.35 Million | 417.99 Million | 629.84 Million | 656.73 Million |
| Cash at end of period | 411.93 Million | 1.03 Billion | 478.65 Million | 480.35 Million | 417.99 Million | 629.84 Million |
| Capital Expenditure | -129.5 Million | -63 Million | -63.86 Million | -63.35 Million | -84.4 Million | -44.07 Million |
| Effect of forex changes on cash | 1.06 Million | -744 Thousand | -813 Thousand | 1.6 Million | 823 Thousand | -2.01 Million |
| Net cash flow / Change in cash | -524.48 Million | 557.76 Million | -1.69 Million | 62.35 Million | -211.84 Million | -26.89 Million |
| Free Cash Flow | 354.85 Million | 585.23 Million | 345.89 Million | 347.99 Million | 291.18 Million | 351.63 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 319.02 Million | 112.92 Million | 73.43 Million | 114.85 Million | 251.04 Million | 136.19 Million |
| Depreciation & Amortization | 156.52 Million | 70.42 Million | 71.4 Million | 91.74 Million | 184.46 Million | 92.71 Million |
| Deferred income taxes | - | - | - | -172.96 Million | -301.22 Million | - |
| Stock-based compensation | 19.36 Million | - | - | 19.13 Million | 19.13 Million | - |
| Change in working capital | -13.72 Million | - | - | -29.67 Million | 86.82 Million | - |
| Other non-cash items | 57.47 Million | -112.92 Million | 292.42 Million | 313.85 Million | 407.99 Million | 267.8 Million |
| Investing Cash Flow | 43.34 Million | -136.91 Million | 52.08 Million | -29.32 Million | -44.08 Million | -14.76 Million |
| Investments in PPE | -129.5 Million | -65.47 Million | -64.03 Million | -49.13 Million | -63 Million | -13.87 Million |
| Acquisitions | 9.12 Million | 124 Thousand | 113 Thousand | 11.36 Million | 10.47 Million | -888 Thousand |
| Investment purchases | - | - | -70.2 Million | -1.55 Million | -1.55 Million | - |
| Sales/Maturities of investments | 135.32 Million | -71.56 Million | 116.01 Million | 10 Million | 10 Million | - |
| Other Investing Activities | - | - | 70.2 Million | -76.2 Million | -72.88 Million | -10.55 Million |
| Financing Cash Flow | -1.05 Billion | -642.03 Million | -411.22 Million | -132.24 Million | -45.64 Million | 86.6 Million |
| Debt repayment | -720 Million | -606.27 Million | -182.72 Million | -5.78 Million | -136.19 Million | -130.41 Million |
| Dividends payments | -93.6 Million | -48.08 Million | -45.51 Million | -104.02 Million | -104.02 Million | - |
| Common Stock Repurchased | -7.68 Million | -7.68 Million | - | -9.89 Million | -32.42 Million | -22.52 Million |
| Common Stock Issuance | 31.21 Million | 38.89 Million | - | -21.35 Million | -32.42 Million | - |
| Other Financing Activities | -152.15 Million | -18.88 Million | -162.66 Million | -2.75 Million | 259.42 Million | -28.73 Million |
| Accounts receivables | -68.27 Million | - | - | 23.77 Million | 23.77 Million | - |
| Accounts payables | 63.84 Million | - | - | - | 116.5 Million | - |
| Inventory | -9.3 Million | - | - | -53.45 Million | -53.45 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 936.41 Million | 871.04 Million | 1.03 Billion | 860.4 Million | 478.65 Million | 478.65 Million |
| Cash at end of period | 411.93 Million | 411.93 Million | 871.04 Million | 1.03 Billion | 1.03 Billion | 860.4 Million |
| Capital Expenditure | -129.5 Million | -65.47 Million | -64.03 Million | -49.13 Million | -63 Million | -13.87 Million |
| Effect of forex changes on cash | 1.06 Million | - | -686 Thousand | 621 Thousand | -744 Thousand | -1.36 Million |
| Net cash flow / Change in cash | -524.48 Million | -459.11 Million | -165.36 Million | 176 Million | 557.76 Million | 381.75 Million |
| Free Cash Flow | 354.85 Million | 152.6 Million | 230.41 Million | 287.82 Million | 585.23 Million | 297.4 Million |
ADEA
E5H
8018
6690
SCPPF
3204